Mb, Levis & Associates, LLC Eli Lilly & CO Transaction History
Mb, Levis & Associates, LLC
- $215 Billion
- Q1 2025
A detailed history of Mb, Levis & Associates, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Mb, Levis & Associates, LLC holds 162 shares of LLY stock, worth $133,076. This represents 0.06% of its overall portfolio holdings.
Number of Shares
162
Previous 162
-0.0%
Holding current value
$133,076
Previous $125 Million
6.98%
% of portfolio
0.06%
Previous 0.06%
Shares
3 transactions
Others Institutions Holding LLY
# of Institutions
4,374Shares Held
759MCall Options Held
10.2MPut Options Held
11.4M-
Lilly Endowment Inc Indianapolis, IN96MShares$78.9 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA74.2MShares$61 Billion1.03% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$54.1 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.3MShares$42.1 Billion26.72% of portfolio
-
State Street Corp Boston, MA34.3MShares$28.2 Billion1.07% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $781B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...